Your browser doesn't support javascript.
loading
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Benkert, Pascal; Meier, Stephanie; Schaedelin, Sabine; Manouchehrinia, Ali; Yaldizli, Özgür; Maceski, Aleksandra; Oechtering, Johanna; Achtnichts, Lutz; Conen, David; Derfuss, Tobias; Lalive, Patrice H; Mueller, Christian; Müller, Stefanie; Naegelin, Yvonne; Oksenberg, Jorge R; Pot, Caroline; Salmen, Anke; Willemse, Eline; Kockum, Ingrid; Blennow, Kaj; Zetterberg, Henrik; Gobbi, Claudio; Kappos, Ludwig; Wiendl, Heinz; Berger, Klaus; Sormani, Maria Pia; Granziera, Cristina; Piehl, Fredrik; Leppert, David; Kuhle, Jens.
Afiliação
  • Benkert P; Department of Clinical Research, Clinical Trial Unit, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Meier S; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Schaedelin S; Department of Clinical Research, Clinical Trial Unit, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Yaldizli Ö; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Maceski A; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Oechtering J; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Achtnichts L; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Conen D; Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
  • Derfuss T; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Lalive PH; Department of Neurosciences, Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, University Hospital of Geneva and Faculty of Medicine, Geneva, Switzerland.
  • Mueller C; Department of Medicine, Cardiology Division, Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Müller S; Department of Neurology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Naegelin Y; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Oksenberg JR; Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Pot C; Department of Clinical Neurosciences, Service of Neurology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Salmen A; Department of Neurology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Willemse E; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Kockum I; Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Blennow K; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, University of Gothenburg, Mölndal, Sweden.
  • Zetterberg H; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, University of Gothenburg, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; UK Dementia Research
  • Gobbi C; Department of Neurology, Multiple Sclerosis Center, Neurocenter of Southern Switzerland, Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
  • Kappos L; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Sormani MP; Department of Health Sciences, University of Genoa, Genoa, Italy.
  • Granziera C; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Medicine and Biomedical Engineering, Translational Imaging in Neurology Basel, University Hospital Ba
  • Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Center for Neurology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden.
  • Leppert D; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Kuhle J; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland. Electronic address: jens.kuhle@usb.ch.
Lancet Neurol ; 21(3): 246-257, 2022 03.
Article em En | MEDLINE | ID: mdl-35182510

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article